Findings

What do systematic reviews say?

26 questions · 26 findings · 3 reviews · Hepato-Biliary

No studies found 2 · 7.7%GRADE not reported 1 · 3.8%Very low 14 · 53.8%Low 7 · 26.9%Moderate 2 · 7.7%High 0 · 0%

Sclerotherapy · people with liver cirrhosis and previous oesophageal variceal bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding

The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) (low certainty).

1 finding from 1 review

Beta‐blockers plus Sclerotherapy(1 RCT; 40 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding

It is very uncertain whether the intervention changes beta‐blockers plus Sclerotherapy(1 RCT; 40 participants) (very low certainty).

1 finding from 1 review

Beta‐blockers plus sclerotherapy(4 RCTs; 231 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding

The intervention probably leads to lower beta‐blockers plus sclerotherapy(4 RCTs; 231 participants) (moderate certainty).

1 finding from 1 review

Sclerotherapy plus variceal band ligation(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding

The intervention showed no clear difference in sclerotherapy plus variceal band ligation(No direct RCT) (low certainty).

1 finding from 1 review

Beta‐blockers plus Sclerotherapy(8 RCTs; 370 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding

The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(8 RCTs; 370 participants) (low certainty).

1 finding from 1 review